Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled Trial von Nielsen, Casper K., Øhrstrøm, Caroline C., Houji, Inas J.K., Helsted, Mads M., Krogh, Liva S.L., Johansen, Nicklas J., Hartmann, Bolette, Holst, Jens J., Vilsbøll, Tina, Knop, Filip K.

Volltext

Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial von Johansen, Nicklas J, Dejgaard, Thomas F, Lund, Asger, Schlüntz, Camilla, Frandsen, Christian S, Forman, Julie L, Wewer Albrechtsen, Nicolai J, Holst, Jens J, Pedersen-Bjergaard, Ulrik, Madsbad, Sten, Vilsbøll, Tina, Andersen, Henrik U, Knop, Filip K

Volltext

Effects of short‐acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes von Johansen, Nicklas J., Dejgaard, Thomas F., Lund, Asger, Schlüntz, Camilla, Hartmann, Bolette, Holst, Jens J., Vilsbøll, Tina, Andersen, Henrik U., Knop, Filip K.

Volltext

1192-P: Robust Arginine-Stimulated Glucagon Secretion in Patients with Type 1 Diabetes Independent of Diabetes Duration, Age, HbA1c, and Beta-Cell Secretory Capacity von WARNØE, JULIE, JOHANSEN, NICKLAS J., LUND, ASGER, BAGGER, JONATAN I., WEWER ALBRECHTSEN, NICOLAI J., HARTMANN, BOLETTE, HOLST, JENS J., VILSBØLL, TINA, ANDERSEN, HENRIK U., DEJGAARD, THOMAS F., KNOP, FILIP K.

Volltext

Effect of short‐acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double‐blind placebo‐controlled trial von Johansen, Nicklas J., Dejgaard, Thomas F., Lund, Asger, Schlüntz, Camilla, Larsen, Emil L., Poulsen, Henrik E., Goetze, Jens P., Møller, Holger J., Vilsbøll, Tina, Andersen, Henrik U., Knop, Filip K.

Volltext

1094-P: Short-Acting Exenatide and Markers of Cardiovascular Disease in Type 1 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Trial von JOHANSEN, NICKLAS J., DEJGAARD, THOMAS F., LUND, ASGER, SCHLÜNTZ, CAMILLA, LARSEN, EMIL LIST, POULSEN, HENRIK E., GØTZE, JENS P., MØLLER, HOLGER, VILSBØLL, TINA, ANDERSEN, HENRIK U., KNOP, FILIP K.

Volltext

1685-P: Dapiglutide Is a Dual Agonist on Human GLP-1- and GLP-2-Receptors with a Biased and Prolonged Signaling Profile at the GLP-1R von Gjelstrup, Louise, Lundholt, Betina Kerstin, Larsen, Bjarne D, Johansen, Nicklas J, Olsen, Minna B, Mathiesen, Jesper M

Volltext

IL-6 Inhibitor Ziltivekimab Increases Serum Hemoglobin and Iron Biomarkers in Patients with CKD Stage 3-5: A RESCUE Trial Analysis: PO0484 von Pergola, Pablo E., Davidson, Michael, Devalaraja, Matt, Ivkovic, Milana, Johansen, Nicklas J., Raj, Dominic S., Sode, Birgitte F., Tuttle, Katherine R., Perkovic, Vlado

Volltext

3017: SABR of bony oligometastases, 1-year, efficacy, and toxicity analyses from the Bony-M trial von Spindler, Nicklas J., Felter, Mette v O, Hansen, Olfred, Nielsen, Tine B., Suppli, Morten H., Josipovic, Mirjana, Poulsen, Laurids Ø, Gaard-Petersen, Fatma, Andersen, Michael B., Sand, Hella M B, Johansen, Marie, Madsen, Kasper, Kornerup, Josefine S., Alsaker, Mirjam D., Serup-Hansen, Eva, Eefsen, Rikke L., Vogelius, Ivan R., Geertsen, Poul, Behrens, Claus P., Persson, Gitte F.

Volltext